These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 34997690)
1. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. Yin F FEBS J; 2023 Mar; 290(6):1420-1453. PubMed ID: 34997690 [TBL] [Abstract][Full Text] [Related]
2. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268 [TBL] [Abstract][Full Text] [Related]
3. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition. Ooi KM; Vacy K; Boon WC Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029 [TBL] [Abstract][Full Text] [Related]
4. Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Zhao L; Mao Z; Woody SK; Brinton RD Neurobiol Aging; 2016 Jun; 42():69-79. PubMed ID: 27143423 [TBL] [Abstract][Full Text] [Related]
5. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis. Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423 [TBL] [Abstract][Full Text] [Related]
6. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction. Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098 [TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Analysis of Lipid Metabolism Genes in Alzheimer's Disease: Highlighting Pathological Outcomes and Compartmentalized Immune Status. Sun Y; Jiang M; Long X; Miao Y; Du H; Zhang T; Ma X; Zhang Y; Meng H J Mol Neurosci; 2024 May; 74(2):55. PubMed ID: 38776015 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236 [TBL] [Abstract][Full Text] [Related]
9. The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease. Shinohara M; Sato N Adv Exp Med Biol; 2019; 1128():85-101. PubMed ID: 31062326 [TBL] [Abstract][Full Text] [Related]
10. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
11. The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View. Penke B; Paragi G; Gera J; Berkecz R; Kovács Z; Crul T; VÍgh L Curr Alzheimer Res; 2018; 15(13):1191-1212. PubMed ID: 30207230 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism. Bonfili L; Cuccioloni M; Gong C; Cecarini V; Spina M; Zheng Y; Angeletti M; Eleuteri AM Clin Nutr; 2022 Mar; 41(3):698-708. PubMed ID: 35158177 [TBL] [Abstract][Full Text] [Related]
13. The involvement of lipids in Alzheimer's disease. Lim WL; Martins IJ; Martins RN J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353 [TBL] [Abstract][Full Text] [Related]
14. Lipids and Alzheimer's Disease. Kao YC; Ho PC; Tu YK; Jou IM; Tsai KJ Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098382 [TBL] [Abstract][Full Text] [Related]
15. Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities. Kawade N; Yamanaka K FEBS Open Bio; 2024 Feb; 14(2):194-216. PubMed ID: 37330425 [TBL] [Abstract][Full Text] [Related]
16. Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Caldwell CC; Yao J; Brinton RD Neurotherapeutics; 2015 Jan; 12(1):66-80. PubMed ID: 25534394 [TBL] [Abstract][Full Text] [Related]
18. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics. Di Domenico F; Barone E; Perluigi M; Butterfield DA Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's brains show inter-related changes in RNA and lipid metabolism. Barbash S; Garfinkel BP; Maoz R; Simchovitz A; Nadorp B; Guffanti A; Bennett ER; Nadeau C; Türk A; Paul L; Reda T; Li Y; Buchman AS; Greenberg DS; Seitz A; Bennett DA; Giavalisco P; Soreq H Neurobiol Dis; 2017 Oct; 106():1-13. PubMed ID: 28630030 [TBL] [Abstract][Full Text] [Related]
20. Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer's Risk in Female Brain. Wang Y; Shang Y; Mishra A; Bacon E; Yin F; Brinton R Sci Rep; 2020 May; 10(1):8528. PubMed ID: 32444841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]